Key statistics
On Thursday, Nautilus Biotechnology Inc (NAUT:NSQ) closed at 2.38, 8.68% above its 52-week low of 2.19, set on Jun 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.36 |
---|---|
High | 2.43 |
Low | 2.28 |
Bid | 1.92 |
Offer | 3.00 |
Previous close | 2.34 |
Average volume | 154.64k |
---|---|
Shares outstanding | 125.56m |
Free float | 70.75m |
P/E (TTM) | -- |
Market cap | 298.84m USD |
EPS (TTM) | -0.561 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 20:59 GMT.
More ▼
- Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
- Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
- Nautilus Biotechnology Reports Third Quarter 2024 Financial Results
- Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024
- Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer
- Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Nautilus Biotechnology Reports Second Quarter 2024 Financial Results
- Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024
- Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Nautilus Biotechnology Reports First Quarter 2024 Financial Results
More ▼